Article Text

Download PDFPDF
Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma
  1. M Ikeguchi1,
  2. T Sakatani2,
  3. T Ueta3,
  4. K Fukuda1,
  5. S Oka1,
  6. K Hisamitsu1,
  7. K Yamaguchi1,
  8. S Tsujitani1,
  9. N Kaibara1
  1. 1Department of Surgery I, Faculty of Medicine, Tottori University, 36–1 Nishi-cho, Yonago 683–8504, Japan
  2. 2Department of Pathology I, Faculty of Medicine, Tottori University, Nishi-cho 86–1, Yonago 683–8503, Japan
  3. 3Department of Pathology II, Faculty of Medicine, Tottori University, Nishi-cho 86–1, Yonago 683–8503, Japan
  1. Correspondence to:
 Dr M Ikeguchi, Department of Surgery I, Faculty of Medicine, Tottori University, 36–1 Nishi-cho, Yonago 683–8504, Japan;
 surgery1{at}grape.med.tottori-u.ac.jp

Abstract

Aim: The lysosomal protease cathepsin D has been reported to be associated with tumour progression in malignant tumours. Expression of the gene encoding cathepsin D is known to be stimulated by oestrogen in mammary cancer cells. Recent experiments revealed that a p53 DNA binding site is located in the promoter region of the cathepsin D gene. This fact indicates that cathepsin D expression may correlate with p53 protein expression. The purpose of this study is to evaluate the expression patterns of the cathepsin D and p53 proteins in oesophageal squamous cell carcinoma (SCC).

Methods: In 154 patients with oesophageal SCC, expression of the cathepsin D and p53 proteins was measured in tumours by means of immunohistochemistry using monoclonal antibodies against cathepsin D (clone, 1C11) and p53 (clone, BP53–12).

Results: Cathepsin D was detected in tumour cells, although it was not found in normal oesophageal epithelium adjacent to carcinoma. High cathepsin D expression (positive tumour cells > 10%) was detected in 76 of 154 cases (49%) and high p53 nuclear expression (positive tumour cells > 50%) was detected in 70 cases (46%). High cathepsin D expression was significantly associated with invasive tumour growth (p = 0.002), poor prognosis (p = 0.049), and nuclear accumulation of p53 protein (p = 0.001). Overexpression of both p53 and cathepsin D was seen in 45 of the 154 cases (29.2%). In addition, there was a positive correlation between the cathepsin D index (percentage of cathepsin D positive tumour cells) and Ki-67 labelling index (percentage of Ki-67 positive tumour cells) in 154 oesophageal SCCs (ρ = 0.257; p = 0.009). However, in multivariate survival analysis, cathepsin D expression by the tumours was not an independent prognostic factor in patients with oesophageal SCC (p = 0.236).

Conclusions: The expression of cathepsin D by cancer cells may play an important role in the invasive growth of oesophageal SCC. Overexpression of both p53 and cathepsin D was seen frequently in tumours; p53 gene abnormalities may correlate with cathepsin D overexpression in oesophageal SCC.

  • cathepsin D
  • oesophageal squamous cell carcinoma
  • immunohistochemistry
  • p53 protein accumulation
  • CD, cathepsin D
  • CI, confidence interval
  • HR, hazards ratio
  • LI, labelling index
  • PBS, phosphate buffered saline
  • SCC, squamous cell carcinoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes